MDM2 and acute myeloid leukemia: It has further been found that ALRN-6924 inhibits the p53-MDM2/MDMX interactions and activates p53, thus inhibiting cell proliferation and clonogenic capacity and causing cell cycle arrest and apoptosis in AML cells harboring wild-type p53 (100).